Proskauer Advises Celgene In $7.2B Receptos Acquisition
Guided by Proskauer Rose LLP, biopharmaceutical company Celgene Corp. said Tuesday that it has agreed to purchase Receptos Inc. in a deal valued at $7.2 billion in order to expand its...To view the full article, register now.
Already a subscriber? Click here to view full article